Last reviewed · How we verify

NCT07475858

Photobiomodulation, Heart Rate Variability, and Acute Stress

Not yet recruiting NA Last updated 17 March 2026
What this trial tests

NA trial testing Vielight Vagus in Stress in 40 participants. Not yet recruiting.

Timeline
1 April 2026
Primary endpoint
31 May 2027
31 August 2027

Quick facts

Lead sponsorBrigham and Women's Hospital
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingsingle
Primary purposeother
Enrollment40
Start date1 April 2026
Primary completion31 May 2027
Estimated completion31 August 2027

Drugs / interventions tested

Conditions studied

Sponsor

Brigham and Women's Hospital

Who can join

Adults 18 to 64, any sex, with Stress. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Photobiomodulation (PBM) is a form of light therapy that uses red or near-infrared light to influence biological processes. In prior studies, PBM has been shown to improve various physiological functions, including tissue repair, inflammation, and cognitive performance. However, little is known about its impact on autonomic nervous system regulation. Thus, the goal of this study is to evaluate the effects of PBM on vagal activity, as measured by heart rate variability (HRV), in healthy adults undergoing experimental stress.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Stress

Currently open trials in the same condition.

Other Brigham and Women's Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07475858.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing